Content about Pharmaceuticals policy

August 12, 2010
PhRMA: Four states develop majority of mental illness treatments

The companies working on more than half of the mental illness drugs under development are...

WASHINGTON The companies working on more than half of the mental illness drugs under development are clustered in four U.S. states, according to research by the largest lobby for the drug industry.

 

The Pharmaceutical Research and Manufacturers of America compiled a study showing that of the 313 drugs, 192 are under development by companies in New York, New Jersey, North Carolina and California. The drugs are in clinical trials or under review by the Food and Drug Administration, PhRMA said.

 

 

August 11, 2010
GPhA: Banning patent settlements will cost money, not save it

The main lobbying group for the generic drug industry said federal authorities erred in projecting...

August 10, 2010
L.A. Times article on Rx information draws response from NACDS

A group representing the drug retailing industry has responded to an article published in the...

August 9, 2010
Antibiotic use increases among elderly patients enrolled in Medicare Part D, study finds

As elderly patients have found improved coverage of prescription drugs after enrolling in Medicare Part...

August 9, 2010
Revenue, profit rise for Watson in Q2

Generic drug maker Watson Pharmaceuticals posted strong sales for second quarter 2010, according to an...

August 9, 2010
Teva completes Ratiopharm acquisition

Israeli drug maker Teva Pharmaceutical Industries has finished its $5 billion acquisition of German generic...

August 4, 2010
Cardinal sees modest revenue gains in FY 2010

Drug distribution and health services titan Cardinal Health on Thursday reported a modest gain in...

August 3, 2010
Pfizer's Q2 sales get boost from specialty drugs

Pfizer had a big increase in sales and a modest increase in profits during second...

August 3, 2010
Watson names two new EVPs

Generic drug maker Watson Pharmaceuticals has appointed two new executives this week....

August 2, 2010
Teva gets closer to completing Ratiopharm acquisition

Teva Pharmaceutical Industries got closer to finishing its $5 billion acquisition of German drug maker...

August 1, 2010
Online pharmacy provider, advocacy group partner to deliver low-cost meds in Ohio

A nonprofit health advocacy group in Ohio has teamed up with a fast-growing mail-order pharmacy...

July 21, 2010
Forest, Merz announce Namenda patent settlements

Several generic drug makers have settled with Forest Labs and German drug maker Merz Pharma...

July 21, 2010
GPhA: Generic drug utilization can curb wasteful Medicaid spending

A reported excess of a quarter billion dollars is a good case for increasing use...

WASHINGTON A reported excess of a quarter billion dollars is a good case for increasing use of generic drugs under the Medicaid program, according to the main lobby for the generic drug industry.

 

Responding to a report by conservative think tank the American Enterprise Institute that identified $271 million in wasteful Medicaid spending, the Generic Pharmaceutical Association said it was a “compelling case” for increasing generic drug utilization.

 

 

July 18, 2010
DEA ends restrictions on controlled substance e-Rx

With a regulatory stroke, the Obama White House has swept away the last serious legal...

July 18, 2010
RediClinic now offering Vaniqa, Lustra to patients

RediClinic, which operates more than 20 clinics in H-E-B grocery stores in Houston and Austin,...

HOUSTON RediClinic, which operates more than 20 clinics in H-E-B grocery stores in Houston and Austin, has expanded its menu of services with the addition of prescription medications Vaniqa and Lustra.

July 18, 2010
Resolving a simmering dispute, ousted Medicare plan agrees to pay

The independent pharmacy lobby is hailing an agreement by Fox Insurance to begin paying overdue...

July 18, 2010
Tidmarsh joins Spectrum

Biotechnology company Spectrum Pharmaceuticals has appointed a new SVP, chief scientific officer and head of...

July 18, 2010
USPS Saturday cuts a Rx game-changer?

Community pharmacy never really was able to stop the mail-order juggernaut. But the U.S. Postal...

July 18, 2010
‘Good Medicines’ vs. ‘Bad Drugs’ awareness could curb Rx abuse

According to recent studies, anti-drug campaigns haven’t sunk in among a large and growing number...

July 15, 2010
Castellani successfully can fill Tauzin's shoes

It’s been said many times that the people you know are as important as what...

WHAT IT MEANS AND WHY IT'S IMPORTANT It’s been said many times that the people you know are as important as what you know. In the case of Billy Tauzin, former president and CEO of the Pharmaceutical Research and Manufacturers of America, this adage was especially true, considering his former career as a member of Congress.

(THE NEWS: PhRMA names new president, CEO. For the full story, click here)

July 15, 2010
Personal Care Products Council supports expanded FDA role in industry oversight

The Personal Care Products Council announced on July 15 that it is calling for a...

WASHINGTON The Personal Care Products Council announced on July 15 that it is calling for a greater role by the Food and Drug Administration in regulatory oversight of personal care products and assessing ingredient safety.

The announcement came less than a week before the introduction of the Safe Cosmetics Act of 2010 in Congress by Reps. Jan Schakowsky, D-Ill., Ed Markey, D-Mass., and Tammy Baldwin, D-Wis.

July 14, 2010
Gilead sues Lupin over patent infringement

Drug maker Gilead Sciences has filed a suit against Indian generic drug maker Lupin for...

July 14, 2010
Keryx gets orphan-drug designation for neuroblastoma treatment

The Food and Drug Administration has given special designation to an investigational treatment for a...

July 14, 2010
Mylan acquires Bioniche Pharma

Generic drug maker Mylan is hoping to gain entry into the injectable drug market with...

July 13, 2010
Teva launches generic Amerge

Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said....

NORTH WALES, Pa. Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said.

 

Teva announced the launch of naratriptan tablets in the 1 mg and 2.5-mg strengths. The tablets are a generic version of GlaxoSmithKline’s Amerge. The drug is used to treat acute migraine attacks in adults with or without visual disturbances preceding the attacks known as aura.